Post Hoc Biomarker Analyses from a Phase 4, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of Repository Corticotropin Injection (Acthar® Gel) for Persistently Active Systemic Lupus Erythematosus

INTRODUCTION: We conducted post hoc analyses of biomarker results from a multicenter, randomized, double-blind, placebo-controlled study of repository corticotropin injection (RCI; Acthar® Gel) in patients with persistently active systemic lupus erythematosus (SLE) despite treatment with moderate-do...

Descripción completa

Detalles Bibliográficos
Autores principales: Askanase, Anca D., Wright, Dale, Zhao, Enxu, Zhu, Julie, Bilyk, Roman, Furie, Richard A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2021
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8572274/
https://www.ncbi.nlm.nih.gov/pubmed/34478124
http://dx.doi.org/10.1007/s40744-021-00351-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8572274/
https://www.ncbi.nlm.nih.gov/pubmed/34478124
http://dx.doi.org/10.1007/s40744-021-00351-7

Ejemplares similares